CN101878213B - α-氟烷基丁苯那嗪和二氢丁苯那嗪成像剂和探针 - Google Patents
α-氟烷基丁苯那嗪和二氢丁苯那嗪成像剂和探针 Download PDFInfo
- Publication number
- CN101878213B CN101878213B CN2008801188947A CN200880118894A CN101878213B CN 101878213 B CN101878213 B CN 101878213B CN 2008801188947 A CN2008801188947 A CN 2008801188947A CN 200880118894 A CN200880118894 A CN 200880118894A CN 101878213 B CN101878213 B CN 101878213B
- Authority
- CN
- China
- Prior art keywords
- compound
- alpha
- fluoroalkyl
- enantiomer
- dihydrotetrabenazinein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 0 *C(CN1C(C2)c3cc(*)c(*)cc3CC1)C2=O Chemical compound *C(CN1C(C2)c3cc(*)c(*)cc3CC1)C2=O 0.000 description 7
- YJMOCCLMPFZLIC-KBAYOESNSA-N CC(C)(CCF)C[C@H](CN(CCc1c2)[C@H](C3)c1cc(OC)c2OC)[C@@H]3O Chemical compound CC(C)(CCF)C[C@H](CN(CCc1c2)[C@H](C3)c1cc(OC)c2OC)[C@@H]3O YJMOCCLMPFZLIC-KBAYOESNSA-N 0.000 description 1
- ZMLKUYPTLNDVMQ-MISYRCLQSA-N CC(C)(CCF)C[C@H](CN(CCc1c2)[C@H](C3)c1cc(OC)c2OC)[C@@H]3OC(C)=O Chemical compound CC(C)(CCF)C[C@H](CN(CCc1c2)[C@H](C3)c1cc(OC)c2OC)[C@@H]3OC(C)=O ZMLKUYPTLNDVMQ-MISYRCLQSA-N 0.000 description 1
- QFAUQAFZHHXGFH-KBAYOESNSA-N CC(C)(CCF)C[C@H](CN(CCc1c2)[C@H](C3)c1cc(OC)c2OC)[C@@H]3OC(N)=O Chemical compound CC(C)(CCF)C[C@H](CN(CCc1c2)[C@H](C3)c1cc(OC)c2OC)[C@@H]3OC(N)=O QFAUQAFZHHXGFH-KBAYOESNSA-N 0.000 description 1
- VOQYWEUJKYJXCS-NRFANRHFSA-N CC(C)OC(C([C@H](c(c(CC1)c2)cc(OC)c2OC)N1C(OC(C)(C)C)=O)C(OC(C)C)=O)=O Chemical compound CC(C)OC(C([C@H](c(c(CC1)c2)cc(OC)c2OC)N1C(OC(C)(C)C)=O)C(OC(C)C)=O)=O VOQYWEUJKYJXCS-NRFANRHFSA-N 0.000 description 1
- WKFBXPAHXAMPAM-MRXNPFEDSA-N CC(C)OC(C[C@H](c(c(CC1)c2)cc(O)c2[O](C)C)N1C(OC(C)(C)C)=O)=O Chemical compound CC(C)OC(C[C@H](c(c(CC1)c2)cc(O)c2[O](C)C)N1C(OC(C)(C)C)=O)=O WKFBXPAHXAMPAM-MRXNPFEDSA-N 0.000 description 1
- BILPHRIGHSDVBQ-PSBUXNCMSA-N CCC[C@H](CN(CCc1c2)[C@H](C3)c1cc(OC)c2OC)[C@@H]3OC1OCCCC1 Chemical compound CCC[C@H](CN(CCc1c2)[C@H](C3)c1cc(OC)c2OC)[C@@H]3OC1OCCCC1 BILPHRIGHSDVBQ-PSBUXNCMSA-N 0.000 description 1
- CFFKDWNBAXWNCX-GFCCVEGCSA-N CCN(CCc1c2)[C@H](CF)c1cc(OC)c2OC Chemical compound CCN(CCc1c2)[C@H](CF)c1cc(OC)c2OC CFFKDWNBAXWNCX-GFCCVEGCSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/947275 | 2007-11-29 | ||
| US11/947,215 | 2007-11-29 | ||
| US11/947,275 | 2007-11-29 | ||
| US11/947215 | 2007-11-29 | ||
| US11/947,275 US7910738B2 (en) | 2007-11-29 | 2007-11-29 | Intermediates for alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes |
| US11/947,215 US7902364B2 (en) | 2007-11-29 | 2007-11-29 | Alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes |
| US12/174,167 US8053578B2 (en) | 2007-11-29 | 2008-07-16 | Alpha-fluoroalkyl dihydrotetrabenazine imaging agents and probes |
| US12/174,167 | 2008-07-16 | ||
| US12/174167 | 2008-07-16 | ||
| PCT/US2008/084601 WO2009070552A1 (en) | 2007-11-29 | 2008-11-25 | Alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101878213A CN101878213A (zh) | 2010-11-03 |
| CN101878213B true CN101878213B (zh) | 2013-05-29 |
Family
ID=40297912
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008801188947A Expired - Fee Related CN101878213B (zh) | 2007-11-29 | 2008-11-25 | α-氟烷基丁苯那嗪和二氢丁苯那嗪成像剂和探针 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US8053578B2 (enExample) |
| EP (2) | EP2594568A1 (enExample) |
| JP (1) | JP2011505363A (enExample) |
| CN (1) | CN101878213B (enExample) |
| WO (1) | WO2009070552A1 (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011153157A2 (en) * | 2010-06-01 | 2011-12-08 | Auspex Pharmaceutical, Inc. | Benzoquinolone inhibitors of vmat2 |
| WO2013041621A1 (de) * | 2011-09-20 | 2013-03-28 | Basf Se | Niedermolekulare modulatoren des kälte-menthol-rezeptors trpm8 und deren verwendung |
| JP6362601B2 (ja) | 2012-09-18 | 2018-07-25 | オースペックス・ファーマシューティカルズ・インコーポレイテッドＡｕｓｐｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． | 小胞モノアミン輸送体２の重水素化ベンゾキノリン阻害剤の製剤薬物動態 |
| US9550780B2 (en) | 2012-09-18 | 2017-01-24 | Auspex Pharmaceuticals, Inc. | Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 |
| EP2951178A4 (en) * | 2013-01-31 | 2016-07-06 | Auspex Pharmaceuticals Inc | VMAT2 INHIBITORS OF BENZOQUINOLONE TYPE |
| WO2015048370A1 (en) * | 2013-09-27 | 2015-04-02 | Auspex Pharmaceuticals, Inc. | Benzoquinolone inhibitors of vmat2 |
| WO2015077521A1 (en) * | 2013-11-22 | 2015-05-28 | Auspex Pharmaceuticals, Inc. | Benzoquinoline inhibitors of vesicular monoamine transporter 2 |
| CA2930744A1 (en) | 2013-12-03 | 2015-06-11 | Auspex Pharmaceuticals, Inc. | Methods of manufacturing benzoquinoline compounds |
| MX2016009817A (es) * | 2014-01-27 | 2017-02-28 | Auspex Pharmaceuticals Inc | Inhibidores de benzoquinolina del transportador vesicular de monoaminas 2. |
| IL288712B2 (en) | 2015-03-06 | 2024-01-01 | Auspex Pharmaceuticals Inc | Methods for the treatment of abnormal involuntary movement disorders |
| HRP20250868T1 (hr) * | 2021-03-22 | 2025-09-26 | Neurocrine Biosciences, Inc. | Vmat2 inhibitori i postupci za uporabu |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4193998A (en) * | 1977-06-15 | 1980-03-18 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt | 1,2,3,4,6,7-Hexahydro-11BαH-benzo[a]quinolizine-derivatives |
| WO1993016730A1 (en) * | 1992-02-28 | 1993-09-02 | The Trustees Of The University Of Pennsylvania | Iodine derivatives of tetrabenazyne |
| CN1980924A (zh) * | 2004-02-11 | 2007-06-13 | 剑桥实验室（爱尔兰）有限公司 | 二氢丁苯那嗪类及包含它们的药用组合物 |
| WO2007130365A2 (en) * | 2006-05-02 | 2007-11-15 | The Trustees Of The University Of Pennsylvania | Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1068261B (de) * | 1959-11-05 | F. Hoffmann-La Roche £v Co. Aktiengesellschaft, Basel (Schweiz) | Verfahren zur Herstellung von substituierten 2-Oxobenzo-chinollizinen | |
| US2843591A (en) | 1958-07-15 | Method for preparing same | ||
| CA2623794A1 (en) | 2005-06-29 | 2007-01-11 | The Trustees Of Columbia University In The City Of New York | Use of dtbz for imaging endocrine pancreas and beta cell mass in type 1 diabetes |
| US20110257220A1 (en) | 2005-08-06 | 2011-10-20 | Cambridge Laboratories (Ireland) Limited | 3,11 b-cis-Dihydrotetrabenazine for the Treatment of Schizophrenia and Other Psychoses |
| US8008500B2 (en) | 2007-06-08 | 2011-08-30 | General Electric Company | Intermediates useful for making tetrabenazine compounds |
| US7902364B2 (en) * | 2007-11-29 | 2011-03-08 | General Electric Company | Alpha-fluoroalkyl tetrabenazine and dihydrotetrabenazine imaging agents and probes |
-
2008
- 2008-07-16 US US12/174,167 patent/US8053578B2/en not_active Expired - Fee Related
- 2008-11-25 JP JP2010536109A patent/JP2011505363A/ja not_active Ceased
- 2008-11-25 EP EP20130155403 patent/EP2594568A1/en not_active Withdrawn
- 2008-11-25 EP EP08854913A patent/EP2217599A1/en not_active Ceased
- 2008-11-25 CN CN2008801188947A patent/CN101878213B/zh not_active Expired - Fee Related
- 2008-11-25 WO PCT/US2008/084601 patent/WO2009070552A1/en not_active Ceased
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4193998A (en) * | 1977-06-15 | 1980-03-18 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt | 1,2,3,4,6,7-Hexahydro-11BαH-benzo[a]quinolizine-derivatives |
| WO1993016730A1 (en) * | 1992-02-28 | 1993-09-02 | The Trustees Of The University Of Pennsylvania | Iodine derivatives of tetrabenazyne |
| CN1980924A (zh) * | 2004-02-11 | 2007-06-13 | 剑桥实验室（爱尔兰）有限公司 | 二氢丁苯那嗪类及包含它们的药用组合物 |
| WO2007130365A2 (en) * | 2006-05-02 | 2007-11-15 | The Trustees Of The University Of Pennsylvania | Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2011505363A (ja) | 2011-02-24 |
| US20090142276A1 (en) | 2009-06-04 |
| CN101878213A (zh) | 2010-11-03 |
| EP2594568A1 (en) | 2013-05-22 |
| EP2217599A1 (en) | 2010-08-18 |
| US8053578B2 (en) | 2011-11-08 |
| WO2009070552A1 (en) | 2009-06-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101878213B (zh) | α-氟烷基丁苯那嗪和二氢丁苯那嗪成像剂和探针 | |
| ES2584653T3 (es) | Sonda para la obtención de imágenes de Tau | |
| CA2715390A1 (en) | Imaging agents for detecting neurological dysfunction | |
| CN105814023A (zh) | tau成像探针 | |
| CN101889013A (zh) | 作为成像剂和探针的氟烷基丁苯那嗪甲醇化合物 | |
| Lee et al. | Synthesis and evaluation of 6-(3-[18F] fluoro-2-hydroxypropyl)-substituted 2-pyridylbenzothiophenes and 2-pyridylbenzothiazoles as potential PET tracers for imaging Aβ plaques | |
| JP2020523292A (ja) | α７ニコチン性アセチルコリン受容体のリガンド化合物及びその応用 | |
| JP2013507345A (ja) | インビボイメージング剤としてのフルマゼニルの［１８ｆ］標識類似体 | |
| WO2007127262A2 (en) | Enantiomers of 2'-fluoralkyl-6-nitroquipazine as serotonin transporter positron emission tomography imaging agents and antidepressant therapeutics | |
| JP2551643B2 (ja) | 放射性ヨー素化ベンズアミドおよびそれを有効成分とするイメージング試薬 | |
| CN101998956A (zh) | 氟化二氢丁苯那嗪醚成像剂和探针 | |
| US20140288317A1 (en) | Aryloxyanilide imaging agents | |
| Wadsak et al. | Radiosynthesis of 3‐(2′‐[18F] fluoro)‐flumazenil ([18F] FFMZ) | |
| EP3835293B1 (en) | Monoamine oxidase b imaging probe | |
| JP6488045B2 (ja) | アセチルコリン小胞トランスポーターの検出に適した化合物 | |
| JP6496101B2 (ja) | アセチルコリン小胞トランスポーターの検出に適した化合物 | |
| Kumar et al. | Synthesis and in vivo evaluation of [O-methyl-11C](2R, 4R)-4-hydroxy-2-[2-[2-[2-(3-methoxy) phenyl] ethyl] phenoxy] ethyl-1-methylpyrrolidine as a 5-HT2A receptor PET ligand | |
| Wang et al. | Synthesis of carbon-11 labeled biaryl 1, 2, 3, 4-tetrahydroisoquinoline derivatives and conformationally flexible analogues as new potential PET glioma tumor imaging agents | |
| JP2021102593A (ja) | タウを画像化する新規化合物 | |
| HK1227034A1 (en) | Tau imaging probe |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130529 Termination date: 20151125 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |